Catalyst Wire Dossier Catalyst Wire Dossier

Triprilimab

JS001
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Triprilimab, covering 2020-06-09 to 2022-06-09. Get the full timeline:

Most recent: Clinical Trial Update: TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer [Phase 2]

See pricing